Trump confirmed taking Ozempic before July?

This market will resolve to "Yes" if definitive evidence confirming that Donald Trump is currently or has recently (since January 1, 2024) been using Ozempic, Wegovy, or another GLP-1 receptor agonist primarily prescribed for weight loss or type 2 diabetes, is made public by June 30, 2025, 11:59 PM ET. Otherwise, this market will resolve to "No". Qualifying evidence includes but is not limited to public statements from Trump, a named personal physician, official medical records or other definitive evidence. Unverified or anonymous claims, or documents not substantiated by credible reporting will not qualify. The primary resolution source will be a consensus of credible reporting, and official information from Donald Trump.